List of works - Stefano Bellentani

"Two drinks per day does not take your fatty liver away".

scientific article published on 21 December 2017

A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders.

scientific article

ASH and NASH ⬇️

scientific article published on 05 July 2011

BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared ⬇️

scientific article published on 01 December 1984

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

scientific article

Cow's Milk Consumption and Health: A Health Professional's Guide

scientific article published on 24 September 2018

Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.

scientific article published in February 2018

Hepatitis B virus markers on dried blood spots. A new tool for epidemiological research ⬇️

scientific article published on July 1, 1981

Microbiota, NASH, HCC and the potential role of probiotics

scientific article

Natural history of nonalcoholic steatohepatitis-associated hepatocellular carcinoma

scientific article published on 27 October 2016

Nonalcoholic fatty liver disease burden - Switzerland 2018-2030

scientific article published on 17 December 2019

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence

scientific article published on 23 August 2018

PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: perspectives in the diagnosis of pancreatic cancer.

scientific article published on 8 November 2014

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

article

Sex differences in the hepatic uptake of sulphobromophthalein in the rat

scientific article published in November 1985

The epidemiology of non-alcoholic fatty liver disease.

scientific article published on January 2017

Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins

scientific article published on March 31, 1992

List of works by Stefano Bellentani

"Two drinks per day does not take your fatty liver away".

A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders.

ASH and NASH ⬇️

BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared ⬇️

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

Cow's Milk Consumption and Health: A Health Professional's Guide

Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.

Hepatitis B virus markers on dried blood spots. A new tool for epidemiological research ⬇️

Microbiota, NASH, HCC and the potential role of probiotics

Natural history of nonalcoholic steatohepatitis-associated hepatocellular carcinoma

Nonalcoholic fatty liver disease burden - Switzerland 2018-2030

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence

PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: perspectives in the diagnosis of pancreatic cancer.

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

Sex differences in the hepatic uptake of sulphobromophthalein in the rat

The epidemiology of non-alcoholic fatty liver disease.

Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins